Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/16/26 16:30 | 6/16/26 | AURA | Health | BioPrd | Biological Products, (No Diag | Gibney Anthony S | MA | O | See Rema | 2 | S.d | -90 | 6.29 | 0 | -14 | 265 | D | |||||||||||||||
5/11/26 16:16 | 5/7/26 | AURA | Health | BioPrd | Biological Products, (No Diag | Matrix Capital Management Company, LP | NH | T | 1 | S | -39,045 | 5.64 | 0 | -6,923 | -100 | 0 | I | |||||||||||||||
4/16/26 18:49 | 4/16/26 | AURA | Health | BioPrd | Biological Products, (No Diag | Kilroy Conor | MA | O | See Rema | 3 | S | -183 | 5.90 | 0 | -31 | 218 | D | |||||||||||||||
2/17/26 19:47 | 2/17/26 | AURA | Health | BioPrd | Biological Products, (No Diag | Plavsic Mark | MA | O | CTO | 2 | S | -158 | 5.61 | 0 | -28 | 197 | D | |||||||||||||||
2/17/26 19:47 | 2/17/26 | AURA | Health | BioPrd | Biological Products, (No Diag | Hopkins Janet Jill | MA | O | Chief Me | 2 | S | -196 | 5.22 | 0 | -38 | 253 | D | |||||||||||||||
2/17/26 19:47 | 2/17/26 | AURA | Health | BioPrd | Biological Products, (No Diag | Elazzouzi Amy | MA | O | SVP,Fina | 5 | S.d | -113 | 5.77 | 0 | -20 | 87 | D | |||||||||||||||
2/17/26 19:46 | 2/17/26 | AURA | Health | BioPrd | Biological Products, (No Diag | De Los Pinos Elisabet | MA | DO | See Rema | 3 | S | -381 | 5.17 | 0 | -74 | 602 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |